Princess Margaret Cancer Research

Toronto, Ontario M5GG 1L7

1 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia (AML), Higher-Risk Myelodysplastic Syndrome (HR-MDS), Locally Advanced Solid Tumor, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Colorectal Cancer (mCRC), Metastatic Solid Tumor, Multiple Myeloma, Newly Diagnosed Intermediate/High-Risk MDS, Relapsed/Refractory Multiple Myeloma (RRMM)

Studies at this site

• A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1) — Recruiting now
• Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications — Completed
• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed